Cargando…

Assessment of Hyperosmolar Blood–Brain Barrier Opening in Glioblastoma via Histology with Evans Blue and DCE-MRI

Background: While the blood–brain barrier (BBB) is often compromised in glioblastoma (GB), the perfusion and consequent delivery of drugs are highly heterogeneous. Moreover, the accessibility of drugs is largely impaired in the margins of the tumor and for infiltrating cells at the origin of tumor r...

Descripción completa

Detalles Bibliográficos
Autores principales: Conq, Jérôme, Joudiou, Nicolas, Ucakar, Bernard, Vanvarenberg, Kevin, Préat, Véronique, Gallez, Bernard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377677/
https://www.ncbi.nlm.nih.gov/pubmed/37509598
http://dx.doi.org/10.3390/biomedicines11071957
_version_ 1785079577136070656
author Conq, Jérôme
Joudiou, Nicolas
Ucakar, Bernard
Vanvarenberg, Kevin
Préat, Véronique
Gallez, Bernard
author_facet Conq, Jérôme
Joudiou, Nicolas
Ucakar, Bernard
Vanvarenberg, Kevin
Préat, Véronique
Gallez, Bernard
author_sort Conq, Jérôme
collection PubMed
description Background: While the blood–brain barrier (BBB) is often compromised in glioblastoma (GB), the perfusion and consequent delivery of drugs are highly heterogeneous. Moreover, the accessibility of drugs is largely impaired in the margins of the tumor and for infiltrating cells at the origin of tumor recurrence. In this work, we evaluate the value of methods to assess hemodynamic changes induced by a hyperosmolar shock in the core and the margins of a tumor in a GB model. Methods: Osmotic shock was induced with an intracarotid infusion of a hypertonic solution of mannitol in mice grafted with U87-MG cells. The distribution of fluorescent dye (Evans blue) within the brain was assessed via histology. Dynamic contrast-enhanced (DCE)-MRI with an injection of Gadolinium-DOTA as the contrast agent was also used to evaluate the effect on hemodynamic parameters and the diffusion of the contrast agent outside of the tumor area. Results: The histological study revealed that the fluorescent dye diffused much more largely outside of the tumor area after osmotic shock than in control tumors. However, the study of tumor hemodynamic parameters via DCE-MRI did not reveal any change in the permeability of the BBB, whatever the studied MRI parameter. Conclusions: The use of hypertonic mannitol infusion seems to be a promising method to increase the delivery of compounds in the margins of GB. Nevertheless, the DCE-MRI analysis method using gadolinium-DOTA as a contrast agent seems of limited value for determining the efficacy of opening the BBB in GB after osmotic shock.
format Online
Article
Text
id pubmed-10377677
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-103776772023-07-29 Assessment of Hyperosmolar Blood–Brain Barrier Opening in Glioblastoma via Histology with Evans Blue and DCE-MRI Conq, Jérôme Joudiou, Nicolas Ucakar, Bernard Vanvarenberg, Kevin Préat, Véronique Gallez, Bernard Biomedicines Article Background: While the blood–brain barrier (BBB) is often compromised in glioblastoma (GB), the perfusion and consequent delivery of drugs are highly heterogeneous. Moreover, the accessibility of drugs is largely impaired in the margins of the tumor and for infiltrating cells at the origin of tumor recurrence. In this work, we evaluate the value of methods to assess hemodynamic changes induced by a hyperosmolar shock in the core and the margins of a tumor in a GB model. Methods: Osmotic shock was induced with an intracarotid infusion of a hypertonic solution of mannitol in mice grafted with U87-MG cells. The distribution of fluorescent dye (Evans blue) within the brain was assessed via histology. Dynamic contrast-enhanced (DCE)-MRI with an injection of Gadolinium-DOTA as the contrast agent was also used to evaluate the effect on hemodynamic parameters and the diffusion of the contrast agent outside of the tumor area. Results: The histological study revealed that the fluorescent dye diffused much more largely outside of the tumor area after osmotic shock than in control tumors. However, the study of tumor hemodynamic parameters via DCE-MRI did not reveal any change in the permeability of the BBB, whatever the studied MRI parameter. Conclusions: The use of hypertonic mannitol infusion seems to be a promising method to increase the delivery of compounds in the margins of GB. Nevertheless, the DCE-MRI analysis method using gadolinium-DOTA as a contrast agent seems of limited value for determining the efficacy of opening the BBB in GB after osmotic shock. MDPI 2023-07-11 /pmc/articles/PMC10377677/ /pubmed/37509598 http://dx.doi.org/10.3390/biomedicines11071957 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Conq, Jérôme
Joudiou, Nicolas
Ucakar, Bernard
Vanvarenberg, Kevin
Préat, Véronique
Gallez, Bernard
Assessment of Hyperosmolar Blood–Brain Barrier Opening in Glioblastoma via Histology with Evans Blue and DCE-MRI
title Assessment of Hyperosmolar Blood–Brain Barrier Opening in Glioblastoma via Histology with Evans Blue and DCE-MRI
title_full Assessment of Hyperosmolar Blood–Brain Barrier Opening in Glioblastoma via Histology with Evans Blue and DCE-MRI
title_fullStr Assessment of Hyperosmolar Blood–Brain Barrier Opening in Glioblastoma via Histology with Evans Blue and DCE-MRI
title_full_unstemmed Assessment of Hyperosmolar Blood–Brain Barrier Opening in Glioblastoma via Histology with Evans Blue and DCE-MRI
title_short Assessment of Hyperosmolar Blood–Brain Barrier Opening in Glioblastoma via Histology with Evans Blue and DCE-MRI
title_sort assessment of hyperosmolar blood–brain barrier opening in glioblastoma via histology with evans blue and dce-mri
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377677/
https://www.ncbi.nlm.nih.gov/pubmed/37509598
http://dx.doi.org/10.3390/biomedicines11071957
work_keys_str_mv AT conqjerome assessmentofhyperosmolarbloodbrainbarrieropeninginglioblastomaviahistologywithevansblueanddcemri
AT joudiounicolas assessmentofhyperosmolarbloodbrainbarrieropeninginglioblastomaviahistologywithevansblueanddcemri
AT ucakarbernard assessmentofhyperosmolarbloodbrainbarrieropeninginglioblastomaviahistologywithevansblueanddcemri
AT vanvarenbergkevin assessmentofhyperosmolarbloodbrainbarrieropeninginglioblastomaviahistologywithevansblueanddcemri
AT preatveronique assessmentofhyperosmolarbloodbrainbarrieropeninginglioblastomaviahistologywithevansblueanddcemri
AT gallezbernard assessmentofhyperosmolarbloodbrainbarrieropeninginglioblastomaviahistologywithevansblueanddcemri